Primary study on herceptin combined with DDP to the vivo action for culture of human ovarian cancer with Her-2/neu overexpression

( views:, downloads: )
Author:
LI Ai-hua()
JIN Wei-guo()
LIU Wei()
ZHOU Hong()
TIAN Chun()
YUAN Tong()
Journal Title:
CANCER RESEARCH AND CLINIC
Issue:
Volume 18, Issue 05, 2006
DOI:
Key Word:

Abstract:

  • [1]Yang H,Zhang G,Xu K.c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance[J].Zhonghua Zhongliu Zazhi,1998,20(5):367-370.
  • [2]Mano M S,Awada A,Di Leo A,et al.Rates of topoisomerase Ⅱ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma[J].Gynecol Oncol,2004,92(3):887-895.
  • [3]Baselga J.Clinical trials of single-agent trastuzumab (Herceptin)[J].Semin Oncol,2000,27(5):20-26.
  • [4]Hung M C,Lau Y K.Basic science of HER-2/neu:a review[J].Semin Oncol,1999,26(4):51-59.
  • [5]Fornier M,Esteva F J,Seidman A D.Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer[J].Semin Oncol,2000,27(6):38-45.
  • [6]Fornier M,Esteva F J,Seidman A D.Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer[J].Semin Oncol,2000,27(6):38-45.
  • [7]Pegram M,Hsu S,Lewis G,et al.Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers[J].Oncogene,1999,18(13):2241-2251.
  • [8]罗荣成,李爱民,张军一,等.Herceptin治疗HER-2过度表达的转移性乳腺癌[J].中华肿瘤杂志,2004,26(1):52-54.
  • [9]Wiechen K,Karaaslan S,Turzynski A,et al.Suppression of the cerbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SKOV3 ovarian cancer cells[J].Br J Cancer,1999,81(5):790-795.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn